Contact person
3 Q&A Interview with Lucian Jon, Operations Director – Denmark, MVA member NES Fircroft
What are the key elements of a successful recruitment process in the life science industry? At NES Fircroft, we believe that successful recruitment in the life science industry is built on deep sector knowledge, access to specialised talent, including strong local networks, and close, long-term...
3 Q&A with interview with Amar Fakhry, Founder and Senior Consultant, PharmaGroup ApS
What are your long-term goals and how do you expect to benefit from your new Medicon Valley Alliance membership? At PharmaGroup, our long-term focus is to strengthen compliance within Good Distribution Practice (GDP) across the life science sector in the Nordics and beyond. We aim to position...
3 Q&A with interview with Sofia Adolfsson, Scientific Officer, MVA member TATAA
How has the GLP accreditation changed the way you work at TATAA? Data quality has always been a central focus for us, but achieving GLP accreditation has elevated it to a new level. It strengthens all our services, supporting not only regulated bioanalysis but also biomarker studies such as...
3 Q & A Interview with Sofia Wallström, CEO, The Swedish Association of the Pharmaceutical Industry, LIF, new member of Medicon Valley Alliance
1) Although the bi-national Swedish Danish Medicon Valley cluster is explicitly highlighted in the Draghi-report, it does not feature prominently in the national Swedish life science strategy. Why do you think that is? The Medicon Valley cluster is undoubtedly a key asset for Nordic and European...
3 Q&A interview with Camilla Oldgren, new CEO of GBA Key2Compliance
1) What do you see as the key challenges and key opportunities for life science in the Nordics in general and the Medicon Valley region in particular? The life science sector in the Nordics - especially in Medicon Valley - has strong foundations in research, innovation, and industry. However,...
3 Q&A interview with Tom Ng from new MVA member company Fios Genomics
1) When did you first hear of Medicon Valley and why did you decide to become a member of the Medicon Valley Alliance? As a leading hub for life science research, the Medicon Valley has been a key focus for Fios Genomics’ international development. We’ve been supporting the work of several...
3 Q&A interview with Liesbeth Ceelen from new MVA member company BioLizard
When did you first learn of the Medicon Valley cluster? We became aware of the Medicon Valley cluster as part of our international growth strategy. The region’s strong network of prominent life science organizations and its professional, innovation-driven ecosystem made it a natural fit for...
4 Q&A Interview about regenerative leadership with Marianne Evie Storgaard, Partner Promentum and former life science executive
1) What is new about regenerative leadership and organizational development? "Regenerative" means to restore or bring forth new life. For too long, we have structured and managed our organizations in ways that deplete both the system and the people within it. Many organizations have become...
3 Q&A Interview with Ulrika Hedlund, CEO and Founder at new MVA member HUMVIA
Why is your company called Humvia? Humvia comes from the founders’ initials HUM plus the Latin word for way, VIA. In Swedish, HUM means ‘knowing your stuff’ and can also relate to the word Human. So, in short, Humvia facilitates and helps people and organisations utilise their knowledge and find...
3 Q&A Interview with Duane Mancini, CEO Project Medtech
From an international and US perspective, why do you find the Medicon Valley cluster interesting? The Medicon Valley cluster is fascinating as a successful model of cross-border collaboration, demonstrating how shared goals and geographical proximity can create a powerful innovation hub for others...